Hinxton,  Cambridge 
United Kingdom
  • Booth: 831

Creating a new standard in genomic medicine


Congenica is a UK company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and regional genetic testing laboratories. We’ve translated this research into the gold standard clinical genomic analytics platform, Sapientia®, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide actionable interpretation of genetic disease for patients. Our platform is used by clinicians and researchers across the world for clinical diagnosis, prognosis, and research. Many of the UK Regional Genetics Centres are using Sapientia as a decision support platform, in addition to clinical laboratories in other countries. It is also being leveraged by several prolific research projects, as well as by UCB Pharma. Sapientia has many other applications in personalised medicine, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers.